Skip to main content

25-02-2020 | Renal cell carcinoma | Conference coverage | Video

Metastatic RCC updates from ASCO GU 2020

Speakers: Bernard Escudier and Viktor Grünwald

Bernard Escudier and Viktor Grünwald take us through the metastatic renal cell carcinoma studies that caught their attention at the 2020 Genitourinary Cancers Symposium, including long-term data from the CheckMate 214 trial and studies of novel agents such as the HIF-2α inhibitor MK-6482 and sitravatinib.

This independent video was supported by an educational grant from Pfizer and Merck KGaA.

Image Credits